Back to News
Market Impact: 0.18
Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform
Source: PR Newswire
Healthcare & BiotechManagement & GovernanceProduct LaunchesTechnology & Innovation
Nutromics, a Melbourne-based DNA-sensing startup, appointed Professor Kevin W. Plaxco as chief scientific officer as it prepares to launch its first product. The leadership hire supports the company's scientific and commercialization efforts in DNA-based sensing, but the announcement provides no product timeline, financial metrics, or commercial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
More News
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- The mobile ambitions of SpaceX see telecom stocks get hit again. What the latest developments mean.
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%
- OpenAI nears up to $30 billion funding round at $1.25 trillion valuation led by UAE investors
- Volvo Cars posts Q3 loss of 3.7 billion crowns, to cut 2,500 jobs
- Moderna shares plunge after leak of partial cancer vaccine data
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Write an Investment Memo with AI: A Decision-Record Template
- Best AI to Write Earnings Notes for Sell-Side Analysts